Dr. Reddy’s Laboratories Ltd. ADR [RDY] stock prices are saw in change for the day to $14.58 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The RDY shares have gain 2.75% over the last week, with a monthly amount glided 5.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] stock has seen the most recent analyst activity on June 05, 2025, when HSBC Securities upgraded its rating to a Buy but kept the price target unchanged to $16.90 for it. Previously, Nomura downgraded its rating to Neutral on December 19, 2024. On January 11, 2024, downgrade downgraded it’s rating to Underperform. HSBC Securities downgraded its rating to a Hold. Bernstein downgraded its rating to a Mkt Perform. BofA Securities upgraded its rating to Buy for this stock on March 17, 2023. In a note dated January 30, 2023, JP Morgan initiated an Underweight rating.
The stock price of Dr. Reddy’s Laboratories Ltd. ADR [RDY] has been fluctuating between $12.26 and $16.19 over the past year. Dr. Reddy’s Laboratories Ltd. ADR [NYSE: RDY] shares were valued at $14.58 at the most recent close of the market.
Analyzing the RDY fundamentals
The Dr. Reddy’s Laboratories Ltd. ADR [NYSE:RDY] reported sales of 3.93B for trailing twelve months, representing a surge of 8.55%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.23%, and Net Profit Margin reading is 0.17%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.17 and Total Capital is 0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.53 points at the first support level, and at 14.48 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.66, and for the 2nd resistance point, it is at 14.74.
Ratios To Look Out For
It’s worth pointing out that Dr. Reddy’s Laboratories Ltd. ADR [NYSE:RDY]’s Current Ratio is 1.89. As well, the Quick Ratio is 1.36, while the Cash Ratio is 0.06. Considering the valuation of this stock, the price to sales ratio is 3.09, the price to book ratio is 2.98 and price to earnings (TTM) ratio is 18.24.
